Locations
United States · North America · Hayward, CA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series B
founded in
2012
DiaCarta is a leading precision diagnostic company specializing in translational genomics and personalized diagnostics. The company offers a comprehensive suite of diagnostic products and services, including advanced cancer tests like Rad Tox™, Colo Scape™, and Oncuria®, as well as infectious disease tests. Their proprietary technologies, XNA and isob DNA™, enhance the sensitivity and accuracy of genetic alteration detection, positioning DiaCarta as a leader in the precision diagnostic industry. With a commitment to innovation and patient-centric operations, DiaCarta aims to improve cancer patient management and outcomes through reliable and affordable diagnostics, supported by a strong team of scientists and industry experts.
Something looks off?On-site & Remote